Global Choroidal Neovascularization (CNV) Market 2014-2018

脈絡膜新生血管(Choroidal Neovascularization)のグローバル市場動向(2014-2018)

◆タイトル:Global Choroidal Neovascularization (CNV) Market 2014-2018
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆資料形式:pdf / 英語
Single UserUSD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥305,200見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥381,500見積依頼/購入/質問フォーム
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。


本調査レポートでは、"脈絡膜新生血管(Choroidal Neovascularization)のグローバル市場動向(2014-2018)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況等の情報をお届けいたします。

About CNV
CNV is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though most causes are idiopathic, the known causes are related to degeneration, infections, choroidal tumors and/or trauma. As there is currently no medical treatment for this disease, this abnormal growth can easily lead to impairment of sight or complete loss of vision.
TechNavio’s analysts forecast the Global CNV market will grow at a CAGR of 6.77 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global CNV market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various therapies used in the treatment of CNV
TechNavio’s report, the Global CNV Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global CNV market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
Key Vendors
• Bayer AG
• F. Hoffmann-La Roche Ltd.
• Novartis AG
• Regeneron Pharmaceuticals Inc.
Other Prominent Vendors

• Affitech A/S
• Allergan Inc.
• Chengdu Kanghong Biotech Co. Ltd.
• Gilead Sciences Inc.
• Lpath Inc.
• Mat Biopharma SAS
• Pfizer Inc.
• Promedior Inc.
• QLT Inc.
• Quark Pharmaceuticals Inc.
• Resolvyx Pharmaceuticals Inc.
• Sanwa Kagaku Kenkyusho Co. Ltd.
• Valeant Pharmaceuticals International Inc.

Key Market Driver
• High Patient and Physician Satisfaction.
• For a full, detailed list, view our report.
Key Market Challenge
• High Cost of Treatment.
• For a full, detailed list, view our report.
Key Market Trend
• Strong Competition in the Market.
• For a full, detailed list, view our report.
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
Product Profiles
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Product Portfolio of Current CNV Therapies
08. Clinical Pipeline Portpolio
09. Rate of Incidence and Prevalence
09.1.1 US
10. Geographical Segmentation
10.1 CNV Market in the Americas
10.1.1 Market Size and Forecast
10.2 CNV Market in the EMEA Region
10.2.1 Market Size and Forecast
10.3 CNV Market in the APAC Region
10.3.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Other Prominent Vendors
18.4 Future Vendors to Tap the CNV Market
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global CNV Market 2013-2018 (US$ million)
Exhibit 3: Global CNV Market by Geographical Segmentation 2013
Exhibit 4: CNV Market in the Americas 2013-2018 (US$ million)
Exhibit 5: CNV Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 6: CNV Market in the APAC Region 2013-2018 (US$ million)
Exhibit 7: Product-wise Revenue Share in Global CNV Market 2013 (in Percentage)


Bayer AG , F. Hoffmann-La Roche Ltd., Novartis AG , Regeneron Pharmaceuticals Inc., Affitech A/S, Allergan Inc., Chengdu Kanghong Biotech Co. Ltd., Gilead Sciences Inc., Lpath Inc., Mat Biopharma SAS, Pfizer Inc., Promedior Inc., QLT Inc., Quark Pharmaceuticals Inc., Resolvyx Pharmaceuticals Inc., Sanwa Kagaku Kenkyusho Co. Ltd., Valeant Pharmaceuticals International Inc.



★調査レポート[脈絡膜新生血管(Choroidal Neovascularization)のグローバル市場動向(2014-2018)] (Global Choroidal Neovascularization (CNV) Market 2014-2018 / IRTNTR3528)販売に関する免責事項
[脈絡膜新生血管(Choroidal Neovascularization)のグローバル市場動向(2014-2018)] (Global Choroidal Neovascularization (CNV) Market 2014-2018 / IRTNTR3528)についてEメールでお問い合わせ